Table 1:

Number of people dispensed at least 1 type 2 histamine-2 receptor antagonist (H2RA) in 6 Canadian provinces and sex-standardized period prevalence rates per 100 population, by age stratum and calendar period, 1996–2019

VariableNo. (%) of people
Nova ScotiaOntarioManitobaSaskatchewanAlbertaBritish Columbia
No. of people aged ≥ 65 yr*2017492512374215073184964581084949339
Ranitidine
 1996–199940262 (33)393120 (29)28483 (18)35682 (26)45709 (17)54097 (11)
 2000–200442490 (33)420596 (28)27581 (17)38931 (26)32536 (10)73324 (13)
 2005–200938290 (27)258444 (15)23574 (14)32339 (21)20300 (6)69974 (11)
 2010–201421894 (14)198023 (10)22184 (12)25280 (16)19932 (5)78229 (11)
 2015–201921422 (11)220664 (9)18331 (9)21033 (12)25753 (5)87116 (10)
Non-ranitidine H2RA
 1996–19997476 (6)161132 (12)10714 (7)10660 (8)21036 (8)113269 (24)
 2000–20043861 (3)111198 (7)5173 (3)4933 (3)8949 (3)79343 (14)
 2005–20091847 (1)45334 (3)2336 (1)1973 (1)3663 (1)35999 (6)
 2010–2014762 (< 1)24779 (1)1336 (1)975 (1)2313 (1)14565 (2)
 2015–20191479 (1)35665 (2)1492 (1)1257 (1)1583 (< 1)10359 (1)
No. of people aged < 65 yr*76849412032327115488498751537814924145457
Ranitidine
 1996–199958456 (7)61231 (9)155709 (5)
 2000–200466680 (8)73344 (10)173493 (5)
 2005–200970525 (8)76597 (10)158306 (5)
 2010–201473518 (8)79640 (10)65697 (2)175975 (5)
 2015–201962695 (6)69069 (8)78354 (2)185411 (5)
Non-ranitidine H2RA
 1996–199923992 (3)20312 (3)210365 (6)
 2000–200410764 (1)9401 (1)135079 (4)
 2005–20095297 (1)3745 (< 1)66408 (2)
 2010–20143346 (< 1)2254 (< 1)5717 (< 1)27218 (< 1)
 2015–20192872 (< 1)2368 (< 1)3738 (< 1)14 463 (< 1)
  • * Population estimates as of July 1, 2019.